Infectious Diseases

293 - Antibiotic use in non-intubated children with bronchiolitis in the intensive care unit

535 - Comparison of humoral immunity in Kawasaki Disease (KD) and COVID-19 related Multisystem Inflammatory Syndrome of Childhood (MIS-C)

540 - A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children with Sickle Cell Disease (PNEU–SICKLE)

576 - A Systematic Review on the Safety and Effectiveness of Palivizumab for the Prevention of Serious Lower Respiratory Tract Infection caused by Respiratory Syncytial Virus

294 - Case-Control Study of Pediatric Patients with Carbapenem-Resistant Enterobacterales Blood Stream Infections at Texas Children’s Hospital from 2014-2019

536 - Kawasaki Disease (KD) Criteria Fulfillment and Associated Outcomes in Multisystem Inflammatory Syndrome in Children (MIS-C)

541 - A Significant Reduction in Congenital Cytomegalovirus (cCMV) Prevalence Has Been Observed During the COVID-19 Pandemic: Demographic Data from a Universal cCMV Screening Study, Minnesota, 2016–2021

577 - Circulation of Respiratory Viruses in Children Before and During the COVID-19 Pandemic

293 - Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population

295 - Clinical characteristics of pediatric patients with E.Coli O157:H7 or Shiga 1 or 2 toxin diarrhea with subsequent development of hemolytic uremic syndrome

537 - Multisystem Inflammatory Syndrome in Children associated with COVID-19: A comparison study between cohorts from different geographic locations.

542 - Adolescents’ and young adults’ preferences for and perceived barriers to gonorrhea and chlamydia testing

578 - Development and Evaluation of a Multivariable Prediction Model for Influenza Hospitalization in Children

294 - COVID-19 and viral co-infections in infants during the first three COVID-19 waves in New York City

296 - Clinical Outcome Comparison Between ESBL Versus non ESBL Urinary Tract Infection in Children

538 - Multisystem inflammatory syndrome in children: Single-center experience in a pediatric children’s hospital

543 - Antibiotic Stewards?: Prescribing Patterns in Emergency Department Pediatric Urinary Tract Infections

579 - Epidemiology of rhinovirus/enterovirus infection among children less than 5 years of age living in central New York during the COVID-19 pandemic

295 - COVID-19 in Children: Worsening Outcomes During Delta Variant Wave

539 - Predicting IVIG Resistance in Kawasaki Disease with Machine Learning Algorithms augmented with Synthetic Sampling

580 - Hantavirus Pulmonary Syndrome in Pediatric Patients in the United States (1993-2018)

296 - Defining Clinical Phenotypes of COVID Viral Infections and Post-Viral Syndromes

298 - Epidemiology and Management of Pediatric Spondylodiscitis

545 - Clinical Epidemiology of Candidemia in Hospitalized Children

581 - Incidence of Respiratory Syncytial Virus infections in the main pediatric hospital in British Columbia, Canada from September 1st to December 31st, 2021.​

297 - Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children

299 - Evaluation of Group A Streptococcus Screening and Antibiotic Prescription in a Pediatric Emergency Department

546 - Development of a TLR7/8 Agonist Adjuvant Formulation to Overcome Early Life Hyporesponsiveness to Acellular Pertussis Vaccine

582 - Monthly Variability and Climatic Factors Associated with Human Rhinovirus/Enterovirus Nasopharyngeal Sample Positivity on Oahu, Hawai’i from 2016-2019

298 - Outcomes of pediatric monoclonal antibody therapy for Coronavirus Disease 2019 (COVID-19)

300 - Group B Streptococcus Serotype Prevalence and Associated Risk Factors Among Colonized Pregnant Patients

547 - Diagnostic accuracy of multiplex RT-PCR compared to standard bacterial culture for tracheal aspirates in children with suspected pneumonia.

583 - Mucosal Antibody Responses in Infants and Young Children with Respiratory Syncytial Virus (RSV) Infection

299 - Pediatric Patient Outcomes and Complications after SARS-CoV-2 Infection

301 - Health Disparities in Antibiotic Choice in Pediatric Urgent Cares Centers

548 - Longitudinal Immune and Inflammatory Marker Responses In Acutely/Recently HIV Infected Youth After Early Combination Antiretroviral Treatment

584 - Out of home child care as a risk factor for pre-pandemic endemic human coronavirus infections in a birth cohort of children 0-2 years

300 - Pre-pandemic coronavirus antibodies in children and adults

302 - Pathogen Identification and Associated Characteristics in a Cohort of Pediatric Acute Hematogenous Osteomyelitis Patients

549 - Long-Term Infant Outcomes After Congenital Syphilis Exposure, Massachusetts, 2015-2017

585 - Predicting Lead-time Respiratory Syncytial Virus-related Pediatric Hospitalizations from Historic Google Trend Search Activity in the United States

301 - Risk Factors for SARS-CoV-2 Infection in an Ambulatory Setting

303 - Postoperative Antibiotic Exposures in Children Following Spinal Fusion for Scoliosis across U.S. Children’s Hospitals

550 - Low diagnostic utility of serial tracheal aspirate cultures in the PICU

586 - Prevalence and Factors Associated with Guideline Concordant Antiviral Treatment in Children at High Risk for Influenza Complications

302 - Risk Factors for Severe COVID-19 in Children

304 - Rapid, Non-invasive Plasma-Based Microbial Cell-free DNA Next Generation Sequencing (The Karius Test) Outperforms the Standard of Care for the Detection of Kingella kingae Pediatric Spinal Infections

551 - Nanotechnology-directed Rapid Identification of Cytomegalovirus in Urine

587 - Use of recommended antiviral agents in pediatric patients hospitalized with influenza

303 - SARS-CoV-2 Infection and Perioperative Complications in Pediatric Surgical Patients

305 - Risk Factors for Pertussis Infection in Infants

552 - Primary Epstein-Barr virus (EBV) infection in preadolescent children: a prospective study

588 - Viral loads of parainfluenza virus type 3 and severity of respiratory diseases in children

306 - Staphylococcus Aureus Polymerase Chain Reaction Usage for Cutaneous Abscesses in the Pediatric Emergency Department and Impact on Antibiotic Prescribing, a Quality Improvement Project

553 - Safety and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Children Living with HIV: A Phase 3 Trial (PNEU-WAY PED)

305 - The Hyaluronan Receptor RHAMM is Critical for Toll-Like Receptor 7- and SARS-CoV-2-Mediated Increases in Lung Cytokines and Inflammation